Medical technology breakthroughs have led to a radical transformation in patient care by enabling a greater focus on clinical outcomes. Minimally invasive or non-invasive medical technologies, for instance, not only shorten recovery time but also low ....see more
Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020.
The anti-snoring treatment market is poised to reach USD 1,232.6 Million by 2020 from USD 744.7 Million in 2015, growing at a CAGR of 10.6% from 2015 to 2020. Major factors driving the growth of this market include the growing awareness regarding the ill effects of snoring, availability and benefits of anti-snoring treatments, growing geriatric and obese population, presence of a large number of cigarette smokers and alcoholics, and a large pool of untapped snoring population. However, poor efficacy of current anti-snoring treatments available in the market, high cost of some of the anti-snoring treatments, and lack of reimbursement are major factors restraining the growth of this market.
Nuclear medicine equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis. The nuclear medicine equipment market is expected to grow at a single-digit CAGR in the next five years. This market is poised to reach USD 2.13 Billion by 2020 from USD 1.78 Billion in 2015, at a CAGR of 3.6% during the forecast period.
The antimicrobial coatings for medical devices market is segmented on the basis of type of material, device types, and regions. The global antimicrobial coatings for medical devices market is expected to grow at a CAGR of 14.2% from 2015 to 2020 to reach USD 1.17 Billion by 2020 from USD 0.61 Billion in 2015. Factors such as rising awareness about hospital-acquired infections, favorable research and funding environment, technological advancements in antimicrobial coatings, growing implantable devices market, increasing research and development activities for antimicrobial coated cardiovascular devices, high growth in geriatric population, and increasing burden of cardiovascular diseases across the globe are driving the growth of this market.
In this report, the medical lifting sling market is broadly segmented on the basis of product, usage type, material, end user and region. On the basis of products, the medical lifting sling market is broadly segmented into standing slings, seating slings, universal slings, hammock slings, transfer slings, toilet slings, bariatric slings, and others (such as positioning and pivot slings). The transfer sling segment is expected to be the largest segment and will also be the fastest growing segment in the forecast period. This growth can be attributed to the multi-purpose application of the sling. The medical lifting sling market is estimated to grow at a CAGR of 11.4% to reach USD 706.0 Million by 2020.
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
Medical videoscope have huge demand across the globe owing to their wide application areas as well as their flexibility in terms of specification of instruments, which fits in with the various requirements of different procedures. The market has seen an extraordinary amount of technological advancements and breakthroughs in the last few years, as companies have focused on developing products capable of reducing pain, curtailing the number of sick days, and reducing the overall cost of treatment. The global medical videoscopes market was valued at $13.6 Billion in 2014 and is expected to reach $19.0 Billion by 2019, growing at a CAGR of 7.0% from 2014 to 2019.
The cannula market is estimated to grow at a CAGR of 5.6% from 2015 to 2020 to reach $135.5 million by 2020.The report segments the global cannula market by product, by material, by application, by end-users and region. On the basis of material, the market is divided into plastic, metal and silicone. The silicone material is estimated to be the fastest growing segment during the forecast period. On the basis of end users, the cannulas market is divided into hospitals, ambulatory surgical centers, and others (blood banks and home healthcare facilities).
The global smart pills market is segmented on the basis of applications and regions. The market by applications is categorized into capsule endoscopy, drug delivery, and patient monitoring. On the basis of regions, the market is divided into North America, Europe, Asia, and Rest of the World (RoW: Pacific countries, Africa, and Latin America). The Smart pills market in 2014 is valued at $1.56 billion. It is forecasted to reach $3.83 billion in the year 2020, growing at a CAGR of 16.16% (2014 – 2020). This will continue to reach $8.98 billion by the year 2024, growing at a CAGR of 23.7% (2020 – 2024).
The global metabolic testing market is expected to reach $475.75 million by 2019 from $332.78 million in 2014, growing at a CAGR of 7.41% between 2014 and 2019. Rising prevalence of lifestyle diseases is the primary growth driver for this market during the forecast period (2014–2019). Moreover, technological advancements and increasing healthcare expenditure are also expected to drive market growth. However, high cost of equipment and software and reimbursement issues may hinder the growth of this market.
The global nanotechnology-based medical devices market is expected to grow at a significant CAGR of around 11-12% during the forecast period (2014–2019). The market is mainly driven by the growth in aging population, rising adoption of nanotechnology-based medical devices, and increased nanotechnology R&D expenditure. In addition, the governments of several nations are investing heavily in developing and commercializing new nanotechnology products. However, safety issues regarding nanotechnology-based medical devices, stringent regulatory guidelines, and time-consuming approval processes for these devices are hampering the growth of this market to a certain extent. The global nanotechnology-based medical devices market was valued at around $5 billion in 2014 and is poised to grow at a CAGR of around 11-12% during the forecast period (2014 to 2019).
The laboratory accessories market is valued at $327.0 million in 2014. It is expected to reach $504.7 million by 2020, growing at a CAGR of 7.5% from 2014 to 2020. The laboratory accessories market is dominated by North America, it is followed by Europe, Asia and Rest of the world. The Asian market is the fastest growing in the forecast period (2014-2020). Reagent reservoirs is the fastest-growing segment of this market.
The global soft tissue repair market is estimated to grow at a CAGR of 7.5% from 2014 to 2019 to reach $14.7 billion in 2019. The increasing incidence of soft tissue injuries among the active aging population, increasing participation in sports, increasing obesity rate, and increasing healthcare expenditure & lack of substitutes for soft tissue repair surgery are the major factors driving market growth.
The European patient handling equipment market is estimated to grow at a CAGR of 11.4% to reach $5,150.2 million by 2019. The nonmechanical equipment product segment is expected to witness the fastest growth during the forecast period. The European patient handling equipment market by region is segmented into Germany, the U.K., France, Sweden, Denmark, Spain, the Netherlands, Italy, and Rest of Europe (RoE).
The global single-tooth implants and dental bridges market is valued at $3,297.6 million in 2014 and is poised to grow at a CAGR of 7.3% during the forecast period of 2014 to 2019. Rising incidences of dental caries and other periodontal diseases among the aging baby-booming populationand growing aging population who are more prone to tooth loss are the major factors driving the growth of this market. In addition, better hygiene and aesthetics associated with the usage of single-tooth implants is expected to drive the growth of the single-tooth implants, as opposed to dental bridges.
The North American interventional cardiology and peripheral vascular devices market is expected to reach $5,947.5 million by 2018, at a meager CAGR of 2.9%. The slow growth of this market can be attributed to the declining growth in the coronary angioplasty procedural volume (decreasing at a CAGR of around 3.0% during the forecast period) in the U.S.
The global pediatric interventional cardiology market is segmented on the basis of type of devices and geography. Based on the type of device, the market is further segmented into congenital heart defect closure devices, transcatheter heart valves, and others (catheters, guidewires, balloons, and stents). Based on geography, this market is divided into four geographic regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This report also includes the number of pediatric interventional cardiology procedures performed across different regions.
The word “vital” connotes the most significant requirement for sustaining healthy life. Blood pressure, respiratory rate, heart rate and body temperature within a normal range are necessary for the survival of human life and these parameters are referred to as vital signs.
The Europe home healthcare market is segmented as products, services, telehealth, and geography. The products market is further classified into homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, and nutrition and fitness. The home healthcare services market is further segmented into unskilled care, rehabilitation therapy, infusion therapy and respiratory therapy, while the telehealth market includes monitoring devices, services, and managed equipment services. The total market is divided into seven major countries, i.e. Germany, France, U.K., Italy Spain, Russia, and Rest of Europe (RoE).
The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.
The North America home health care market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. Home healthcare market includes products, services, and telehealth. The home care product category comprises homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, fitness, and nutrition products. Services include unskilled care, rehabilitation therapy, infusion therapy, and respiratory therapy, while telehealth includes home telehealth monitoring devices and telehealth services.
According to the American Society for Testing and Materials (ASTM), ’additive manufacturing’ is the “process of joining materials to make objects from 3D model data, usually layer upon layer”. Various synonyms generally used for AM are additive fabrication, additive processes, additive techniques, additive layer manufacturing, layer manufacturing, and freeform fabrication. The AM market can be applied in various industries such as motor vehicles, consumer products, business machines, medical, academic, aerospace, government/military, and others (architecture, paleontology, and forensic pathology). In this report, we are mainly focusing on the medical applications of AM.
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
Bionics is mechanical/electronic replacement or enhancement of organs/parts of living organisms. The medical bionic implants market is a potentially growing one with a global market of $12.67 billion in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017.
Bio-implants can be defined as prostheses used to regularize physiological functions. They are made up of biosynthetic materials like collagen, and tissue-engineered products like artificial skin or tissues. Most bioengineered products like cardiac pacemakers and orthopedic artificial implants are also covered under bio-implants, since they are implanted entirely in the patient’s body.
The global ophthalmology market witnessed a dip during the economic downturn in 2008 and 2009; however, it is poised to grow at a stable rate mainly due to an increasing aging population, large pool of patients with eye diseases, changing demographics and geographical trends, and increased focus on combination therapies of drugs. Moreover, incidences of glaucoma and cataract are increasing every year.
A minimally invasive surgical (MIS) procedure refers to the surgery performed with minute incisions in the body; for instance, plaque blockages in the arteries of the heart and other vessel walls of peripheral organs, such as lower extremities, neck, kidneys, and brain. The principal advantage of these procedures over surgery is short recovery time, small scars, low risk of infection, less bleeding, and shorter hospital stays.
The market for dental diagnostic and surgical equipment consists of devices used in diagnosing dental diseases/conditions and treating the same. These include dental chairs, hand pieces, CAD/CAM systems, scaling units, instrument delivery systems, dental lasers, intra oral and extra oral radiology equipment, and CBCT scanners. The global market for these equipments was valued at $4.5 billion in 2011 and is expected to grow at a CAGR of 5.8% from 2011-2016.
The Asian region is expected to be ruled by the emerging economies such as China and India, show the highest CAGR by the year 2016. The Chinese IVD market is taking frog leap amongst the emerging nations, followed by India, Russia, and Brazil. The major driving factor for the IVD industry to boom in the emerging countries is the government funding and improved healthcare facilities.
The orthopedic devices market is witnessing major growth sue to increasing patient awareness about the advantages of advanced treatments and technologies such as orthobiologics.
The global top 10 medical devices market was expected to be worth $164 billion in the year 2010 and is estimated to reach $228 billion by 2015, growing at a CAGR of 6.8% from 2010 to 2015. The cardiovascular devices, orthopedic devices, and diagnostic imaging devices markets are the major revenue generators for the medical devices industry
Microscopes have been in use since the 17th century and since then, technical advances have greatly widened the scope of microscopy. Digitization has led to greater precision of the images. The development of confocal microscopes and new technologies in electron microscopes is boosting the growth of the microscopy market.
The global anesthesia and respiratory devices market is expected to witness moderate growth in the coming five years. Respiratory devices account for the largest share (about 57%) in this market; primarily due to their wide usage among the three consumer segments (healthcare institutions, home healthcare and transport) as compared to anesthesia devices; which have limited usage amongst the end-users.
The global minimally invasive surgery market is witnessing steady growth due to rapid technological advancements changing demographics and rising awareness amongst the patient population for less invasive procedures or single incision procedures.
The dental devices report forecasts the size of global dental devices and consumables market over the period 2010 – 2015. The report analyses the key trends of the market, and segments the global dental equipment and consumables market by components and into various geographic regions (with the market size for each of these regions). Further, it discusses the key market drivers, restraints and opportunities of the global dental equipment and consumables market.
The Emerging Markets: BRIC (Brazil, Russia, India and China) Patient Monitors witnesses significant growth opportunities due to rapidly aging population, high incidence of chronic diseases, and government initiatives such as reform in healthcare delivery systems. Despite the impact of economic slowdown, BRIC nations are expected to grow at a CAGR of around 10 - 12% from 2009 – 2014.
The global dental implants market is estimated to be $ 4 billion by 2014, growing at a CAGR of 6 %.this is the most promising and dynamic market within dental device market with 18% of market share. The market is expected to grow because of the tremendous demand for cosmetic dentistry and effective treatment for edentulism. The European and North American markets are the top two markets with most promising outlook for the future. The developing economies in Asian and South American regions are also expected to contribute to the growth of the market in the coming years.
Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
This market report will enable strategic understanding on the ophthalmology devices & drugs market. Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles.
In this report, we have analyzed how the home healthcare market is evolving. The increasing population above the age group of 65 years covers about 70% of the entire market, while the elderly support population (population between 20-64 years of age) is declining. The lack of family members to support and care for the elderly at home generates a high demand for home care products and services. Along with this, the increased cost of hospital care services presents the largest opportunity for this market. Thus, many companies are eagerly approaching this segment with several customized products and services.
Dental consumables form the largest segment of the dental industry, and also hold significant potential for further growth due to the increasing incidence of oral disease and growing awareness about oral care. The growth of the dental consumables market is also driven by the demand from the increasing population of aging people across the globe, as well as from the younger generation focusing on dental aesthetics.
This report will provide market estimates and forecast for outsourcing oppportunities within medical equipment and pharma industry. The market segmentation for the same will include products, services, applications, and technologies.
This report analyzes the basic structure of the drug-device combination market and its various submarkets. Individual markets for major products such as anti-microbial catheters, wound-care products, bone-graft substitutes, bone cement, drug-eluting stents, photodynamic therapy, artificial pancreas, and steroid eluting electrodes are further broken down into their respective sub-segments based on products, technology and applications.
This report provides an in-depth review of the numerous significant developments in neurostimulation technology, and the markets for this technology. It also provides in detail the competitive landscape, profiles of key players and over 100 market related tables on the neurostimulation sector.
The report provides market data on the latest and future equipment and technologies in the market. It also analyzes the key market trends, strategies of the key players and provides market data for the next five years. The focus is on the patented equipment and technologies being developed across the globe.
This report will analyze the market potential for minimally invasive/non-invasive surgery. The target segment (end-users) of the minimal invasive/non-invasive surgery products are mainly hospital surgical departments, outpatient surgery centers, group medical practices, individual surgeons, and medical schools. The number of outpatient centers is set to rise, as a low cost alternative for hospitals.